Macclesfield, United Kingdom

Kieran James Lennon

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Cheshire, GB (2014)
  • Macclesfield, GB (2012 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kieran James Lennon: Innovator in Pharmaceutical Formulations

Introduction

Kieran James Lennon is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on innovative formulations that enhance drug bioavailability and efficacy.

Latest Patents

One of Kieran's latest patents is an immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one. This invention relates to a pharmaceutical formulation that includes the drug in a solid dispersion with a matrix polymer exhibiting low hygroscopicity and high softening temperature, such as copovidone. The formulation aims to provide a daily pharmaceutical dose of the drug while increasing its bioavailability.

Career Highlights

Throughout his career, Kieran has worked with prominent companies in the pharmaceutical industry, including Kudos Pharmaceuticals Limited and AstraZeneca. His experience in these organizations has contributed to his expertise in developing innovative drug formulations.

Collaborations

Kieran has collaborated with several professionals in his field, including Julie Kay Cahill and Michael Karl Bechtold. These collaborations have likely enriched his research and development efforts.

Conclusion

Kieran James Lennon is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact drug delivery and effectiveness. His innovative approaches continue to advance the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…